[English] 日本語
 Yorodumi
Yorodumi- PDB-5gtp: The agonist-free structure of human PPARgamma ligand binding doma... -
+ Open data
Open data
- Basic information
Basic information
| Entry | Database: PDB / ID: 5gtp | ||||||
|---|---|---|---|---|---|---|---|
| Title | The agonist-free structure of human PPARgamma ligand binding domain in the presence of the SRC-1 coactivator peptide | ||||||
|  Components | 
 | ||||||
|  Keywords | TRANSCRIPTION / PPARgamma / SRC-1 | ||||||
| Function / homology |  Function and homology information labyrinthine layer morphogenesis / positive regulation of transcription from RNA polymerase II promoter by galactose / regulation of thyroid hormone receptor signaling pathway / positive regulation of female receptivity / prostaglandin receptor activity / :  / negative regulation of receptor signaling pathway via STAT / MECP2 regulates transcription factors / negative regulation of vascular endothelial cell proliferation / negative regulation of extracellular matrix assembly ...labyrinthine layer morphogenesis / positive regulation of transcription from RNA polymerase II promoter by galactose / regulation of thyroid hormone receptor signaling pathway / positive regulation of female receptivity / prostaglandin receptor activity / :  / negative regulation of receptor signaling pathway via STAT / MECP2 regulates transcription factors / negative regulation of vascular endothelial cell proliferation / negative regulation of extracellular matrix assembly / negative regulation of connective tissue replacement involved in inflammatory response wound healing / positive regulation of cholesterol transport / negative regulation of cellular response to transforming growth factor beta stimulus / arachidonate binding / positive regulation of adiponectin secretion / negative regulation of cardiac muscle hypertrophy in response to stress / DNA binding domain binding / lipoprotein transport / NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis / positive regulation of vascular associated smooth muscle cell apoptotic process / WW domain binding / positive regulation of fatty acid metabolic process / STAT family protein binding / male mating behavior / response to lipid / negative regulation of type II interferon-mediated signaling pathway / hypothalamus development / LBD domain binding / negative regulation of cholesterol storage / negative regulation of SMAD protein signal transduction / E-box binding / lipid homeostasis / alpha-actinin binding / R-SMAD binding / cellular response to Thyroglobulin triiodothyronine / negative regulation of vascular associated smooth muscle cell proliferation / monocyte differentiation / negative regulation of blood vessel endothelial cell migration / Synthesis of bile acids and bile salts / white fat cell differentiation / negative regulation of macrophage derived foam cell differentiation / cellular response to low-density lipoprotein particle stimulus / progesterone receptor signaling pathway / negative regulation of lipid storage / negative regulation of BMP signaling pathway / positive regulation of cholesterol efflux / Synthesis of bile acids and bile salts via 27-hydroxycholesterol / cell fate commitment / Endogenous sterols / Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol / response to retinoic acid / negative regulation of osteoblast differentiation / negative regulation of mitochondrial fission / positive regulation of fat cell differentiation / BMP signaling pathway / long-chain fatty acid transport / estrous cycle / nuclear retinoid X receptor binding / histone acetyltransferase activity / cellular response to hormone stimulus / Recycling of bile acids and salts / Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 / histone acetyltransferase / retinoic acid receptor signaling pathway / cell maturation / NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux / negative regulation of MAPK cascade / intracellular receptor signaling pathway / estrogen receptor signaling pathway / hormone-mediated signaling pathway / lactation / :  / positive regulation of adipose tissue development / Regulation of lipid metabolism by PPARalpha / peroxisome proliferator activated receptor signaling pathway / response to nutrient / epithelial cell differentiation / positive regulation of neuron differentiation / regulation of cellular response to insulin stimulus / peptide binding / BMAL1:CLOCK,NPAS2 activates circadian expression / SUMOylation of transcription cofactors / Activation of gene expression by SREBF (SREBP) / response to progesterone / negative regulation of miRNA transcription / cerebellum development / negative regulation of angiogenesis / placenta development / nuclear estrogen receptor binding / nuclear receptor binding / positive regulation of apoptotic signaling pathway / Regulation of PTEN gene transcription / transcription coregulator binding / RNA polymerase II transcription regulatory region sequence-specific DNA binding / hippocampus development / SUMOylation of intracellular receptors / negative regulation of smooth muscle cell proliferation / mRNA transcription by RNA polymerase II / Heme signaling / fatty acid metabolic process Similarity search - Function | ||||||
| Biological species |  Homo sapiens (human) | ||||||
| Method |  X-RAY DIFFRACTION /  SYNCHROTRON /  MOLECULAR REPLACEMENT / Resolution: 2.35 Å | ||||||
|  Authors | Jang, J.Y. / Suh, S.W. | ||||||
|  Citation |  Journal: Biochim. Biophys. Acta / Year: 2017 Title: Structural basis for differential activities of enantiomeric PPAR gamma agonists: Binding of S35 to the alternate site. Authors: Jang, J.Y. / Koh, M. / Bae, H. / An, D.R. / Im, H.N. / Kim, H.S. / Yoon, J.Y. / Yoon, H.J. / Han, B.W. / Park, S.B. / Suh, S.W. | ||||||
| History | 
 | 
- Structure visualization
Structure visualization
| Structure viewer | Molecule:  Molmil  Jmol/JSmol | 
|---|
- Downloads & links
Downloads & links
- Download
Download
| PDBx/mmCIF format |  5gtp.cif.gz | 72.3 KB | Display |  PDBx/mmCIF format | 
|---|---|---|---|---|
| PDB format |  pdb5gtp.ent.gz | 51.6 KB | Display |  PDB format | 
| PDBx/mmJSON format |  5gtp.json.gz | Tree view |  PDBx/mmJSON format | |
| Others |  Other downloads | 
-Validation report
| Summary document |  5gtp_validation.pdf.gz | 456.9 KB | Display |  wwPDB validaton report | 
|---|---|---|---|---|
| Full document |  5gtp_full_validation.pdf.gz | 461.6 KB | Display | |
| Data in XML |  5gtp_validation.xml.gz | 12.6 KB | Display | |
| Data in CIF |  5gtp_validation.cif.gz | 16.6 KB | Display | |
| Arichive directory |  https://data.pdbj.org/pub/pdb/validation_reports/gt/5gtp  ftp://data.pdbj.org/pub/pdb/validation_reports/gt/5gtp | HTTPS FTP | 
-Related structure data
| Related structure data |  5gtnC  5gtoC  3vn2S S: Starting model for refinement C: citing same article ( | 
|---|---|
| Similar structure data | 
- Links
Links
- Assembly
Assembly
| Deposited unit |  
 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 
 | ||||||||
| Unit cell | 
 | 
- Components
Components
| #1: Protein | Mass: 32280.350 Da / Num. of mol.: 1 / Fragment: UNP RESIDUES 223-505 Source method: isolated from a genetically manipulated source Source: (gene. exp.)  Homo sapiens (human) / Gene: PPARG, NR1C3 / Production host:   Escherichia coli (E. coli) / Strain (production host): Rosetta2(DE3) / References: UniProt: P37231 | 
|---|---|
| #2: Protein/peptide | Mass: 1905.186 Da / Num. of mol.: 1 / Source method: obtained synthetically / Source: (synth.)   Homo sapiens (human) / References: UniProt: Q15788*PLUS | 
| #3: Chemical | ChemComp-MYR / | 
| #4: Chemical | ChemComp-GOL / | 
| #5: Water | ChemComp-HOH / | 
-Experimental details
-Experiment
| Experiment | Method:  X-RAY DIFFRACTION / Number of used crystals: 1 | 
|---|
- Sample preparation
Sample preparation
| Crystal | Density Matthews: 2.73 Å3/Da / Density % sol: 54.92 % | 
|---|---|
| Crystal grow | Temperature: 296 K / Method: vapor diffusion, sitting drop / pH: 7 / Details: 2.2 M sodium malonate (pH 7.0) | 
-Data collection
| Diffraction | Mean temperature: 100 K | 
|---|---|
| Diffraction source | Source:  SYNCHROTRON / Site: PAL/PLS  / Beamline: 7A (6B, 6C1) / Wavelength: 0.97934 Å | 
| Detector | Type: ADSC QUANTUM 270 / Detector: CCD / Date: May 21, 2014 | 
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray | 
| Radiation wavelength | Wavelength: 0.97934 Å / Relative weight: 1 | 
| Reflection | Resolution: 2.35→50 Å / Num. obs: 16193 / % possible obs: 99.4 % / Redundancy: 5.8 % / Net I/σ(I): 36.2 | 
| Reflection shell | Resolution: 2.35→2.39 Å / Redundancy: 6.1 % / Rmerge(I) obs: 0.603 / Mean I/σ(I) obs: 4 / % possible all: 100 | 
- Processing
Processing
| Software | 
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure:  MOLECULAR REPLACEMENT Starting model: 3VN2 Resolution: 2.35→30 Å / Cor.coef. Fo:Fc: 0.953 / Cor.coef. Fo:Fc free: 0.933 / SU B: 8.223 / SU ML: 0.19 / Cross valid method: THROUGHOUT / ESU R: 0.306 / ESU R Free: 0.238 / Details: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS 
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Ion probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso  mean: 67.958 Å2 
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: 1  / Resolution: 2.35→30 Å 
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints | 
 | 
 Movie
Movie Controller
Controller












 PDBj
PDBj
















